Single nucleotide polymorphisms and haplotype frequencies of UGT2B4 and UGT2B7 in a Japanese population

Drug Metabolism and Disposition

Volumn 32, Issue 9, 2004, Pages 1048-1054

  Saeki, Mayumi ^a   Saito, Yoshiro ^a   Jinno, Hideto ^a   Tanaka Kagawa, Toshiko ^a   Ohno, Akiko ^a   Ozawa, Shogo ^a   Ueno, Kazuyuki ^b   Kamakura, Shiro ^b   Kamatani, Naoyuki ^c   Komamura, Kazuo ^b   Kitakaze, Masafumi ^b   Sawada, Jun Ichi ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GENOMIC DNA; GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE UGT2B4; GLUCURONOSYLTRANSFERASE UGT2B7; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; DRUG GLUCURONIDATION; ENHANCER REGION; ETHNIC DIFFERENCE; EXON; GENE LINKAGE DISEQUILIBRIUM; HAPLOTYPE; HEART ARRHYTHMIA; HUMAN; HUMAN CELL; INTRON; JAPAN; LEUKOCYTE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; DNA MUTATIONAL ANALYSIS; ETHNIC GROUPS; EXONS; GENETIC SCREENING; GLUCURONOSYLTRANSFERASE; HAPLOTYPES; HUMANS; INTRONS; JAPAN; LEUKOCYTES; LINKAGE (GENETICS); POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); SEQUENCE ANALYSIS; SOFTWARE;

EID: 4143053975     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Barbier O, Duran-Sandoval D, Pineda-Torra I, Kosykh V, Fruchart JC, and Staels B (2003a) Peroxisome proliferator-activated receptor alpha induces hepatic expression of the human bile acid glucuronidating UDP- glucuronosyitransferase 2B4 enzyme. J Biol Chem 278:32852-32860.
2. Barbier O, Torra IP, Sirvent A, Claudel T, Blanquart C, Duran-Sandoval D, Kuipers F, Kosykh V, Fruchart JC, and Staels B (2003b) FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity. Gastroenterology 124:1926-1940.
3. Beaulieu M, Lévesque E, Hum DW, and Bélanger A (1996) Isolation and characterization of a novel cDNA encoding a human UDP-glucuronosyltransferase active on C19 steroids. J Biol Chem 271:22855-22862.
4. Beaulieu M, Lévesque E, Hum DW, and Bélanger A (1998) Isolation and characterization of a human orphan UDP-glucuronosyltransferase, UGT2B11. Biochem Biophys Res Commun 248:44-50.
5. Bhasker CR, McKinnon W, Stone A, Lo AC, Kubota T, Ishizaki T, and Miners JO (2000) Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance. Pharmacogenetics 10:679-685.
6. Carrier JS, Turgeon D, Journault K, Hum DW, and Belanger A (2000) Isolation and characterization of the human UGT2B7 gene. Biochem Biophys Res Commun 272:616-621.
7. Congiu M, Mashford M, Slavin IL, and Desmond PV (2002) UDP glucuronosyltransferase mRNA levels in human liver disease. Drug Metab Dispos 30:129-134.
8. Court MH, Krishnaswamy S, Hao Q, Duan SX, Patten CJ, Von Moltke LL, and Greenblatt DJ (2003) Evaluation of 3′-azido-3′-deoxythymidine, morphine and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism. Drug Metab Dispos 31:1125-1133.
9. Fisher MB, VandenBranden M, Findlay K, Burchell B, Thummel KE, Hall SD, and Wrighton SA (2000) Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGTIAI promoter genotype and variability in a liver bank. Pharmacogenetics 10:727-739.
10. Hirota T, Ieiri I, Takane H, Sano H, Kawamoto K, Aono H, Yamasaki A, Takeuchi H, Masada M, Shimizu E, et al. (2003) Sequence variability and candidate gene analysis in two cancer patients with complex clinical outcomes during morphine therapy. Drug Metab Dispos 31:677-680.
11. Holthe M, Klepstad P, Zahlsen K, Borchgrevink PC, Hagen L, Dale O, Kaasa S, Krokan HE, and Skorpen F (2002) Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy. Eur J Clin Pharmacol 58:353-356.
12. Holthe M, Rakvag TN, Klepstad P, Idle JR, Kaasa S, Krokan HE, and Skorpen F (2003) Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients. Pharmacogenomics J 3:17-26.
13. Ikushiro S, Emi Y, and Iyanagi T (2002) Activation of glucuronidation through reduction of a disulfide bond in rat UDP-glucuronosyltransferase 1A6. Biochemistry 41:12813-12820.
14. Ishii Y, Hansen AJ, and Mackenzie PI (2000) Octamer transcription factor-1 enhances hepatic nuclear factor-1α-mediated activation of the human UDP glucuronosyltransferase 2B7 promoter. Mol Pharmacol 57:940-947.
15. Jackson MR, McCarthy LR, Harding D, Wilson S, Coughtrie MW, and Burchell B (1987) Cloning of a human liver microsomal UDP-glucuronosyltransferase cDNA. Biochem J 242:581-588.
16. Jin CJ, Miners JO, Lillywhite KJ, and Mackenzie PI (1993) cDNA cloning and expression of two new members of the human liver UDP-glucuronosyltransferase 2B subfamily. Biochem Biophys Res Commun 194:496-503.
17. Kitamura Y, Moriguchi M, Kaneko H, Morisaki H, Morisaki T, Toyama K, and Kamatani N (2002) Determination of probability distribution of diplotype configuration (diplotype distribution) for each subject from genotypic data using the EM algorithm. Ann Hum Genet 66:183-193.
18. Lampe JW, Bigler J, Bush AC, and Potter JD (2000) Prevalence of polymorphisms in the human UDP-glucuronosyltransferase 2B family: UGT2B4(D458E), UGT2B7(H268Y) and UGT2B15(D85Y). Cancer Epidemiol Biomarkers Prev 9:329-333.
19. Lévesque E, Beaulieu M, Hum DW and Bélanger A (1999) Characterization and substrate specificity of UGT2B4(E458): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics 9:207-216.
20. Lévesque E, Turgeon D, Carrier J-S, Montminy V, Beaulieu M, and Bélanger A (2001) Isolation and characterization of the UGT2B28 cDNA encoding a novel human steroid conjugating UDP-glucuronosyltransferase. Biochemistry 40:3869-3881.
21. Mackenzie P, Little JM, and Radominska-Pandya A (2003) Glucosidation of hyodeoxycholic acid by UDP-glucuronosyltransferase 2B7. Biochem Pharmacol 65:417-421.
22. Mackenzie PI, Owens IS, Burchell B, Bock KW, Bairoch A, Belanger A, Foumel-Gigleux S, Green M, Hum DW, Iyanagi T, et al. (1997) The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7:255-269.
23. Meech R, Yogalingam G, and Mackenzie PI (1996) Mutational analysis of the carboxy-terminal region of UDP-glucuronosyltransferase 2B1. DNA Cell Biol 15:489-494.
24. Monaghan G, Clarke DJ, Povey S, See CG, Boxer M, and Burchell B (1994) Isolation of a human YAC contig encompassing a cluster of UGT2 genes and its regional localization to chromosome 4q13. Genomics 23:496-499.
25. Ohno A, Saito Y, Hanioka N, Jinno H, Saeki M, Ando M, Ozawa S, and Sawada J (2004) Involvement of human hepatic UGT1A1, UGT2B4, and UGT2B7 in the glucuronidation of carvedilol. Drug Metab Dispos 32:235-239.
26. Pillot T, Ouzzine M, Foumel-Gigleux S, Lafaurie C, Radominska A, Burchell B, Siest G, and Magdalou J (1993) Glucuronidation of hyodeoxycholic acid in human liver. Evidence for a selective role of UDP-glucuronosyltransferase 2B4. J Biol Chem 268:25636-25642.
27. Radominska-Pandya A, Czernik PJ, and Little JM (1999) Structural and functional studies of UDP-glucuronosyltransferases. Drug Metab Rev 31:817-899.
28. Riedy M, Wang JY, Miller AP, Buckler A, Hall J, and Guida M (2000) Genomic organization of the UGT2b gene cluster on human chromosome 4q13. Pharmacogenetics 10:251-260.
29. Ritter JK, Sheen YY, and Owens IS (1990) Cloning and expression of human liver UDP-glucuronosyltransferase in COS-1 cells: 3,4-catechol estrogens and estriol as primary substrates. J Biol Chem 265:7900-7906.
30. Sawyer MB, Innocenti F, Das S, Cheng C, Ramirez J, Pantle-Fisher FH, Wright C, Badner J, Pei D, Boyett JM, et al. (2003) A pharmacogenetic study of uridine diphosphate-glucuronosyltransferase 2B7 in patients receiving morphine. Clin Pharmacol Ther 73:566-574.
31. Tukey RH and Strassburg CP (2000) Human UDP-glucuronosyltransferases: metabolism, expression and disease. Annu Rev Pharmacol Toxicol 40:581-616.
32. Turgeon D, Carrier J-S, Lévesque E, Beatty BG, Bélanger A, and Hum DW (2000) Isolation and characterization of the human UGT2B15 gene, localized within a cluster of UGT2B genes and pseudogenes on chromosome 4. J Mol Biol 295:489-504.
33. Turgeon D, Carrier JS, Levesque E, Hum DW, and Belanger A (2001) Relative enzymatic activity, protein stability and tissue distribution of human steroid-metabolizing UGT2B subfamily members. Endocrinology 142:778-787.